Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.

Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C.

Clin Infect Dis. 2012 May;54 Suppl 4:S362-8. doi: 10.1093/cid/cir987.

2.

Determinants of HIV drug resistance and public health implications in low- and middle-income countries.

Bertagnolio S, De Luca A, Vitoria M, Essajee S, Penazzato M, Hong SY, McClure C, Duncombe C, Jordan MR.

Antivir Ther. 2012;17(6):941-53. doi: 10.3851/IMP2320. Epub 2012 Aug 16. Review.

PMID:
22898622
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.

De Luca A, Hamers RL, Schapiro JM.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S63-9. doi: 10.1093/infdis/jit109. Review.

PMID:
23687291
5.

The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.

Hong SY, Nachega JB, Kelley K, Bertagnolio S, Marconi VC, Jordan MR.

Infect Disord Drug Targets. 2011 Apr;11(2):124-33. Review.

6.

HIV-1 drug resistance and resistance testing.

Clutter DS, Jordan MR, Bertagnolio S, Shafer RW.

Infect Genet Evol. 2016 Dec;46:292-307. doi: 10.1016/j.meegid.2016.08.031. Epub 2016 Aug 29. Review.

PMID:
27587334
7.

Antiretroviral drug supply challenges in the era of scaling up ART in Malawi.

Schouten EJ, Jahn A, Ben-Smith A, Makombe SD, Harries AD, Aboagye-Nyame F, Chimbwandira F.

J Int AIDS Soc. 2011 Jul 6;14 Suppl 1:S4. doi: 10.1186/1758-2652-14-S1-S4. Review.

Supplemental Content

Support Center